Leadless pacemaker and subcutaneous implantable cardioverter-defibrillator therapy: the first use of a novel treatment option in Poland
Krzysztof Kaczmarek(Medical University of Lodz), Paweł Ptaszyński(Medical University of Lodz), Jerzy Krzysztof Wranicz(Medical University of Lodz), Piotr Jakubowski(Medical University of Lodz), Bartosz Czarniak(Medical University of Lodz)
Cited by 5
Related Papers
The SGLT2 inhibitor empagliflozin in patients hospitalized for acute heart failure: a multinational randomized trial
|Nature Medicine|2022|889
Chronic kidney disease and arrhythmias: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference
|European Heart Journal|2018|285
Metoprolol succinate vs. ivabradine in the treatment of inappropriate sinus tachycardia in patients unresponsive to previous pharmacological therapy
|EP Europace|2012|107
Quantitative Assessment of Microvolt T‐Wave Alternans in Patients with Congestive Heart Failure
|Journal of Cardiovascular Electrophysiology|2005|84